Investors

JSC “Progress-88″ is always opened to new ideas, proposals and forms of cooperation.

The new direction that we learn at the moment is the usege of Potassium Osmate (VI) K2[OsO2(OH)4] based on isotope Osmium-187 (187Os) in oncology and gerontology. Based on the results of our research we can confidently conclude that  the further work in this area is very promising. The creation of innovative anti-cancer drug is the main aim for us. Because the creation of medicines is time consuming and costly process, the expansion of external relations and attraction of new partners is a priority for us. Cooperation with us is transparent business practice, the opportunity to become part of a globally significant project and a profitable investment. We welcome your suggestions on possible ways of joint cooperation.